Marex Group »

Rocket Pharmaceuticals shares owned by Marex Group

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Marex Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $93k 29k 3.26
2025-06-30 $55k 23k 2.45

More positions owned by Marex Group

Tesla Motors Call Option (TSLA)
Mastercard Incorporated Cl A (MA)
Booking Holdings (BKNG)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New (MSTR)
UnitedHealth (UNH)
NVIDIA Corporation Call Option (NVDA)
Eli Lilly & Co. (LLY)
Valkyrie Bitcoin (BRRR)
Apple (AAPL)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Marex Group

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Vanguard Group
BlackRock
Millennium Management
Suvretta Capital Management
Monaco Asset Management SAM
Newtyn Management
Maverick Capital
D. E. Shaw & Co
Geode Capital Management
Jpmorgan Chase & Co
Citadel Advisors
Two Sigma Advisers
State Street Corporation
Two Sigma Investments

View all funds holding Rocket Pharmaceuticals